• Valemetostat (DS-3201): EZH2 Research Workflows

  2026-09-19

  Valemetostat (DS-3201) gives researchers a practical way to connect EZH2 genotype, chromatin pharmacodynamics, and lymphoma-cell phenotypes in one workflow. This guide combines dose-response design, epigenetic readouts, MIR9-informed assay selection, and troubleshooting for translational epigenetic cancer therapy studies.

• hiPSC-Derived Sensory Neurons Model HSV-1 Latency

  2026-09-18

  Oh and colleagues developed a scalable human hiPSC-derived sensory neuron system that supports HSV-1 latency and experimentally induced reactivation. The model combines functional neuronal characterization with virologic, transcriptional, and chromatin-based criteria, creating a human-relevant platform for studying latent infection and testing strategies that may limit recurrence.

• HyperScribe mRNA Kit: Assay Design Logic

  2026-09-18

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 connects ARCA capping, modified nucleotides, DNase treatment, and poly(A) tailing to practical assay decisions. This article shows how transcript architecture should be matched to translation, RNA vaccine development, and immune-readout requirements.

• Calpeptin: A Calpain Inhibitor for Fibrosis Research

  2026-09-17

  Calpeptin is a potent calpain inhibitor with a reported 5 nM IC50 for human calpain 1. Evidence from fibroblast, mouse pulmonary fibrosis, and triple-negative breast cancer extracellular-vesicle models supports its use as a research tool, while model-specific limitations prevent direct clinical conclusions.

• Substance P: Reliable Cell Assay Workflows

  2026-09-17

  Learn how Substance P (SKU B6620) can be incorporated into controlled cell viability, proliferation, and cytotoxicity workflows. This scenario-based guide addresses formulation, storage, assay compatibility, interpretation, and vendor reliability using product specifications and relevant analytical evidence.

• AI Prognostic Signature for Hepatocellular Carcinoma

  2026-09-16

  The reference study developed a seven-gene consensus artificial intelligence-derived prognostic signature (CAIPS) by integrating 101 machine-learning workflows across six multi-center hepatocellular carcinoma cohorts. The model improved risk stratification, connected high-risk disease with metabolic dysregulation and genomic instability, and generated testable hypotheses for treatment selection and therapeutic development.

• Tofacitinib Repairs RA Macrophage Dysfunction

  2026-09-16

  The 2026 reference study shows that GM-CSF reprograms rheumatoid arthritis macrophages toward an inflammatory, metabolically stressed state and that tofacitinib reverses this phenotype through GM-CSFRα and STAT5-related mechanisms. Its combination of patient-derived specimens, metabolic perturbation controls, mitochondrial analysis, and preclinical models provides a useful framework for studying cytokine-driven immunometabolic dysfunction.

• Carbapenemase Gene Transmission in CREC Hospitals

  2026-09-15

  Chen et al. integrate carbapenemase-gene localization, conjugative transfer, mobile-element analysis, and clonal typing to characterize carbapenem-resistant Enterobacter cloacae across eight teaching hospitals in Guangdong. The findings emphasize plasmid-associated blaNDM-1, substantial horizontal-transfer potential, and the need to interpret resistance surveillance alongside both genetic mobility and epidemiological relatedness.

• Aneugen Mechanism Profiling in 27 Reference Chemicals

  2026-09-15

  Bernacki et al. developed a tiered flow-cytometry strategy that distinguishes tubulin stabilization, tubulin destabilization, and mitotic kinase inhibition as major mechanisms of chemical-induced aneugenicity. Its combination of fluorescent Taxol response, p-H3:Ki-67 ratios, clustering, and neural-network classification provides a practical framework for moving from genotoxicity detection to molecular-mechanism assignment.

• (-)-Blebbistatin in Cardiac Optogenetic Workflows

  2026-09-14

  Use (-)-Blebbistatin as a reversible non-muscle myosin II inhibitor to separate actomyosin mechanics from voltage readouts in advanced cardiac and cell-based assays. Combined with panoramic optical and electrical mapping, it supports more discriminating studies of contractility, cytoskeletal dynamics, and preparation-specific artifacts.

• Separating Growth Arrest from Cancer Cell Death

  2026-09-14

  Hannah R. Schwartz’s dissertation shows why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a response framework that separates proliferative inhibition from cell killing and emphasizes their different proportions and timing, improving interpretation of in vitro cancer research data.

• Natural Compounds Target SARS-CoV-2 Proteins

  2026-09-13

  This 2022 Journal of Molecular Modeling study combined virtual screening, molecular docking, and molecular dynamics to evaluate natural vitamin-derived compounds against SARS-CoV-2 3CLpro and the spike receptor-binding domain. Its main contribution is a dual-target computational framework that identifies candidates for blocking both viral polyprotein processing and host-cell entry, while also highlighting the need for biochemical and cellular validation.

• Clathrin-Mediated Entry of Type III Grass Carp Reovirus

  2026-09-12

  Wang et al. used inhibitor profiling, transmission electron microscopy, and quantitative PCR to show that genotype III grass carp reovirus enters CIK cells through a dynamin-dependent, clathrin-mediated route requiring endosomal acidification. The study also distinguishes Nystatin-sensitive membrane processes from the entry mechanism used by GCRV104, providing a useful framework for interpreting pharmacological entry assays.

• Polymyxin B and the LPS–Immunity Trade-Off

  2026-09-11

  Polymyxin B sulfate is more than a membrane-active antibiotic benchmark. Its ability to engage Gram-negative bacterial envelopes, influence dendritic-cell signaling, and potentially reshape interpretation of LPS biology makes it a valuable tool for translational infection, immunity, microbiome, and cancer research.

• Sulforaphane, ROS, and NLRP3 in Colitis

  2026-09-11

  A 2024 study found that Sulforaphane reduced disease-associated inflammation in dextran sodium sulfate-induced mouse colitis while suppressing oxidative stress and NLRP3 inflammasome signaling. Its combined mouse and RAW264.7 macrophage experiments support a redox-linked mechanism, but the findings remain preclinical and do not establish direct NLRP3 binding or clinical efficacy.

8401 records 1/561 page Next 12345 下5页 Last page